Services

testing the potency of EVs

Extracellular vesicles (EVs) play an essential role in cellular communication by transporting proteins, lipids as well as nucleic acids. Several in vitro bioassays have been established to test the potency of extracellular vesicles such as assays to test for e.g. anti-inflammatory, neo-angiogenic, anti-fibrotic or wound healing activities.

Related Services

establishment of stable cell lines for production of extracellular vesicles

P-MSC/TERT308

Placental amnion - derived mesenchymal stem cells

MSCs for production of clinical grade extracellular vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about our
EV cell factories

Mesenchymal stem cell line from placental tissue

telomerized cell line from chorioic plate for production of clinical grade extracellular vesicles

CP-MSC/TERT308 cell line

Related Services

production and characterization of extracellular vesicles from human cell lines or primary cells using 2D and 3D cell culture systems

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Print Friendly, PDF & Email